Polypoidal Choroidal Vasculopathy (PCV)
4 clinical trials · Condition
◉ Watch Polypoidal Choroidal Vasculopathy (PCV)
| Record | Firm | Date |
|---|---|---|
| Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial (NCT07389980) | Yeungnam University College of Medicine | 2026-12-24 |
| Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy (NCT07461441) | Yeungnam University College of Medicine | 2026-03-01 |
| A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV) (NCT07365371) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2026-01-01 |
| The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) (NCT03159884) | Chengdu Kanghong Biotech Co., Ltd. | 2015-10-01 |
Track Polypoidal Choroidal Vasculopathy (PCV) automatically
Every clearance here is in the API, with alerts when new ones post.